ELAN R&D Expense Growth

Elanco Animal Health Incorporated Common Stock · R&D Expense Growth

ELAN logo

ELAN R&D Expense Growth

Latest reported6.98%
ELAN FY R&D Growth (YoY) (0.00% → 6.98%)
High-resolution chart · PNG

ELAN r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Elanco Animal Health Incorporated Common Stock R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
6.9767%
5.1988%
1.8692%
-13.0081%
12.844%
21.0663%
9.5296%
-2.0262%
-5.3047%
-8.6598%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.